Gross Profit On Sales Veränderung Datum
AbbVie USD 9.56B 95M 2023-09
Abbott USD 5.68B 147M 2023-12
ALKERMES USD 319.43M 234.71M 2023-09
Amgen USD 5.08B 14M 2023-12
AstraZeneca USD 9.43B 15M 2023-09
Biogen USD 1.77B 102.7M 2023-12
BioMarin Pharmaceutical USD 510.73M 54.14M 2023-12
Bristol-Myers Squibb USD 8.77B 294M 2023-12
Eisai JPY 140.19B 12.82B 2023-09
Eli Lilly USD 7.57B 73.1M 2023-12
Gilead Sciences USD 5.5B 18M 2023-12
GlaxoSmithKline GBP 5.91B 626M 2023-09
Infinity Pharmaceuticals USD 231K 59K 2023-06
J&J USD 14.6B 374M 2023-12
Merck USD 11.29B 441M 2023-12
Neurocrine Biosciences USD 487.6M 46.4M 2023-09
Pacira USD 133.55M 9.38M 2023-12
Perrigo USD 411.2M 16.8M 2023-09
Pfizer USD 7.58B 3.26B 2023-12
Regeneron Pharmaceuticals USD 2.92B 9M 2023-12
Revance Therapeutics USD 37.36M 536K 2023-09
Roche Holding CHF 22.16B 123M 2023-06
UCB EUR 1.79B 24M 2023-06
Ultragenyx Pharmaceutical USD 115.34M 28.28M 2023-12
United Therapeutics USD 543.7M 4.4M 2023-12
Vertex Pharmaceuticals USD 2.16B 19.8M 2023-09
Zoetis USD 1.49B 27M 2023-12



AbbVie Bruttoergebnis Vom Umsatz - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2024.